Related Experiment Videos
Hemodynamics and metabolism in ischemic cerebrovascular disease
1Department of Neurology, Washington University School of Medicine, St. Louis, Missouri.
Insights
Cerebral blood flow (CBF) and cerebral metabolic rate (CMR) measurements offer insights into stroke pathophysiology. However, these techniques remain research tools, lacking demonstrated clinical value for patient care decisions.
Area of Science:
- Neurology
- Cerebrovascular Diseases
- Medical Imaging
Background:
- Cerebral blood flow (CBF) and cerebral metabolic rate (CMR) measurements are crucial for understanding stroke pathophysiology.
- These techniques have guided the development of therapeutic strategies for ischemic cerebrovascular disease.
Purpose of the Study:
- To evaluate the current clinical utility of CBF and CMR measurements in patient care.
- To determine the future role of these techniques in treating ischemic cerebrovascular disease.
Main Methods:
- Review of existing literature on CBF and CMR measurements in human ischemia and infarction.
- Analysis of the potential for therapeutic manipulation combined with CBF and CMR.
Main Results:
- CBF and CMR measurements have provided valuable insights into stroke pathophysiology.
- No demonstrated value for these techniques in individual patient care decisions has been established.
- CBF and CMR are widely available but considered clinical research tools.
Conclusions:
- Further research combining therapeutic manipulation with CBF and CMR is essential for optimal treatment of ischemic cerebrovascular disease.
- CBF and CMR measurements require proven benefits in reducing morbidity, mortality, or costs to be integrated into clinical practice.
Abstract:
Measurements of CBF and CMR in human ischemia and infarction have provided valuable insight into the pathophysiology of stroke and important guidance to the development of therapeutic strategies. Further research combing therapeutic manipulation with CBF and CMR will be important for developing optimal methods to treat ischemic cerebrovascular disease. At this time, no value has been demonstrated for these techniques in individual patient care decisions. Although now widely available, CBF and CMR measurements should still be considered clinical research tools until they can be shown to provide benefit in reducing morbidity and mortality or reducing medical expenses in clinical practice.